Physician profile
Stephen Taylor
NPI 1356349831
$1,014.71
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $264.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $191.80 | 2019-2020 | |
| Amgen INC. | $158.07 | 2019-2020 | |
| Astellas Pharma US INC | $156.90 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.63 | 2019-2020 | |
| Janssen Biotech, INC. | $62.40 | 2019 | |
| Endo Pharmaceuticals INC. | $55.50 | 2019 | |
| Boston Scientific Corporation | $46.56 | 2020 | |
| Ferring Pharmaceuticals INC. | $39.72 | 2019 | |
| Intuitive Surgical, INC. | $27.58 | 2019 | |
| Seagen INC. | $25.47 | 2019 | |
| Blue Earth Diagnostics | $23.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.20 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $22.84 | 2020 | |
| Olympus America INC. | $17.52 | 2020 | |
| 180 Medical, INC. | $17.15 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $17.05 | 2019 | |
| Teleflex LLC | $13.90 | 2020 | |
| Dornier Medtech America, INC | $13.85 | 2020 | |
| Photocure INC | $13.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.